Literature DB >> 9565517

Pulmonary hypertension and trisomy 16.

H R Movahhedian1, I A Kashani, D Sine, D Bull, K L Jones, A Rothman.   

Abstract

An infant girl, born small for gestational age, with abnormal single creases on the fifth digits, subsequent severe developmental delay, hypertelorism, bilateral equinovalgus deformities, grade IV genitourinary reflux and mild right hydronephrosis, was found to have an inverted duplication of the short arm of chromosome 16 [46,XX; inv dup (16) (p 13.3-->p 11.2]. The cardiac anomalies included a large perimembranous ventricular septal defect (VSD) and a moderate-sized atrial septal defect (ASD). Cardiac catheterization at 6 months of age revealed systemic level pulmonary artery pressure, bilateral pulmonary venous desaturation, and in room air a pulmonary/systemic blood flow ratio (Qp/Qs) of 0.8:1.0, which did not change significantly with administration of oxygen and nitric oxide. To our knowledge, this is the first description of early nonreactive pulmonary vascular disease in a patient with duplication 16p and a large VSD.

Entities:  

Mesh:

Year:  1998        PMID: 9565517     DOI: 10.1007/s002469900278

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  3 in total

1.  16p subtelomeric duplication: a clinically recognizable syndrome.

Authors:  Maria Cristina Digilio; Laura Bernardini; Anna Capalbo; Rossella Capolino; Maria Giulia Gagliardi; Bruno Marino; Antonio Novelli; Bruno Dallapiccola
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

2.  "Molecular rulers" for calibrating phenotypic effects of telomere imbalance.

Authors:  C L Martin; D J Waggoner; A Wong; S Uhrig; J A Roseberry; J F Hedrick; S D Pack; K Russell; E Zackai; W B Dobyns; D H Ledbetter
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

3.  16p subtelomeric duplication with vascular anomalies: an Albanian case report and literature review.

Authors:  A Babameto-Laku; V Mokini; N Kuneshka; S Sallabanda; Z Ylli
Journal:  Balkan J Med Genet       Date:  2012-12       Impact factor: 0.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.